Heron Therapeutics Inc
HRTX
|
|
| |
|
| Trading Volume | 44,387 |
|
|
3.88 - 0.54 |
| Market Cap Full | $ 289.6M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 8.9% | 62.4% | -39.6% | -35.4% |
| Q2 | - | 27.2% | -23.2% | -51.2% |
| Q3 | - | -35% | -11.2% | 51.3% |
| Q4 | - | -16.9% | 73.1% | -40.8% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.9 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 41.8 | 10.4 | 3.8 | -4.5 | 40.2 | -6.9 | -13.7 | -35 | - | - | - | 27.1 |
| 2023 | |||||||||||
| 8.4 | -12.6 | -36.3 | 58.3 | -52.3 | 1.8 | 43.1 | -1.2 | -37.2 | -38.2 | 93.1 | 38.2 |
| 2022 | |||||||||||
| -1.7 | -18.5 | -19.4 | -16.1 | -31.3 | -15.5 | -0.5 | 47.4 | 3.2 | -8.8 | -29.6 | -7.8 |
| 2021 | |||||||||||
| -18 | 4.2 | -10.3 | 7.8 | -24.1 | 17 | -20.4 | -5.6 | -8.4 | 3 | -14.2 | -6.2 |
| 2020 | |||||||||||
| -12.5 | -15.7 | -32.8 | 21.5 | 27.8 | -19.3 | 10.7 | -12.2 | 4.8 | 8.9 | 6.3 | 22.2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.3 | -0.6 | -0.6 | -0.6 |
| Q2 | -0.4 | -0.6 | -0.6 | -0.6 |
| Q3 | -0.2 | -0.4 | -0.5 | -0.6 |
| Q4 | 0 | -0.1 | -0.5 | -0.7 |
| A | -0.79 | -1.7 | -2.2 | -2.5 |